Home diagnosis and therapy for obstructive sleep apnea (OSA) may improve access to testing and continuous positive airway pressure (CPAP) treatment. We compared subjective sleepiness, sleep quality, quality of life, BP, and CPAP adherence after 4 weeks of CPAP therapy in subjects in whom OSA was diagnosed and treated at home and in those evaluated in the sleep laboratory.

A randomized trial was performed consisting of home-based level 3 testing followed by 1 week of auto-CPAP and fixed-pressure CPAP based on the 95% pressure derived from the auto-CPAP device, and in-laboratory polysomnography (PSG) (using mostly split-night protocol) with CPAP titration. Read the rest of this entry

The Cuyahoga County New Product Development and Entrepreneurship Loan Fund awarded Cleveland Medical Devices Inc. $60,000 to step up commercialization of the company’s SleepView device for sleep apnea screening at home.

CleveMed has a lineup of wireless diagnostic sleep systems, including SleepView, which is the smallest and lightest home sleep monitor with an American Academy of Sleep Medicine-recommended Type 3 channel set.

“This is all about, how do we start to commercialize this more?” said CleveMed chairman Bob Schmidt. “We want to expand from the hundreds of places [where the device is used] now to thousands of places.”

CleveMed develops innovative biomedical signal processing and instrumentation devices for sleep and movement disorders, like Parkinson’s.

New Sleep Center Opens in Central Washington

Central Washington Sleep Diagnostic Center recently opened it’s second branch in Moses Lake at 2323 W. Broadway Ave., Unit 4.

The sleep center is here to help people experiencing sleeping disorders, as more than 70 million Americans’ sleep is currently affected. The affects of sleep deprivation include depression, brain fog, change in mental status, short-term memory loss, weight gain, high blood pressure, stroke, heart disease, traffic accidents, workplace accidents and injuries. Read the rest of this entry